BRANDON LEE DOVERSPIKE

Allopathic & Osteopathic Physicians|Family Medicine CLARION, PA NPI 1962811497

General Payments — all program years on this page

$3,648.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 223
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $385.09 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $385.0920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $699.0047
2019 $626.6038
2020 $344.4023
2021 $496.2530
2022 $563.9633
2023 $533.5232
2024 $385.0920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078147485 Janssen Pharmaceuticals, Inc $29.97 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086227112 Bayer Healthcare Pharmaceuticals Inc. $21.01 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096751611 Novo Nordisk Inc $17.49 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096924104 Novo Nordisk Inc $14.31 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097162564 Novo Nordisk Inc $24.74 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097507585 Novo Nordisk Inc $21.38 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111565697 Amgen Inc. $17.13 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111565699 Amgen Inc. $18.31 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116418648 GlaxoSmithKline, LLC. $20.71 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118254311 Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124713334 Grifols USA, LLC $20.20 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124713336 Grifols USA, LLC $17.91 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125361886 Abbott Laboratories $23.87 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125361888 Abbott Laboratories $16.75 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136076039 Lilly USA, LLC $16.43 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139341060 Astellas Pharma US Inc $18.77 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139430824 Astellas Pharma US Inc $17.32 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150149600 SHIELD THERAPEUTICS INC $21.21 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153287450 Dexcom, Inc. $13.85 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153287453 Dexcom, Inc. $13.73 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.